A phase 2 study of HLX07 as monotherapy or combination therapy in patients with locally advanced, unresectable, or metastatic esophageal squamous cell carcinoma

被引：0
|
作者：
Huang, Jing
Liu, Yun
Wu, Tao
Liu, Zhen-Yang
Zhou, Jin
Yuan, Yuan
Yang, Mudan
Liu, Bo
Tan, Zhenbo
Zhuang, Wu
Chen, Jiayan
Liu, Yanqing
Yu, Haoyu
Wang, Qingyu
Zhu, Jun
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[2] Anyang Tumor Hosp, Anyang, Peoples R China
[3] Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, Affiliated Canc Hosp, Changsha, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Canc Hosp,Sch Med, Chengdu, Peoples R China
[5] Xuzhou Cent Hosp, Xuzhou, Jiangsu, Peoples R China
[6] Shanxi Canc Hosp, Taiyuan, Peoples R China
[7] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[8] Xingtai Peoples Hosp, Xingtai, Peoples R China
[9] Fujian Canc Hosp, Fuzhou, Peoples R China
[10] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[11] Shanghai Henlius Biotech Inc, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4029
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Local Control With Cemiplimab Monotherapy for Unresectable Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Jaworski, E.
    Sun, Y.
    Schonewolf, C.
    Gharzai, L. A.
    Mierzwa, M. L.
    Tsung, I.
    Swiecicki, P. L.
    Worden, F.
    Shah, J. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E417 - E417
  • [32] Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
    Doki, Y.
    Ajani, J. A.
    Kato, K.
    Xu, J.
    Wyrwicz, L.
    Motoyama, S.
    Ogata, T.
    Kawakami, H.
    Hsu, C. -H.
    Adenis, A.
    El Hajbi, F.
    Di Bartolomeo, M.
    Braghiroli, M. I.
    Holtved, E.
    Ostoich, S. A.
    Kim, H. R.
    Ueno, M.
    Mansoor, W.
    Yang, W. -C.
    Liu, T.
    Bridgewater, J.
    Makino, T.
    Xynos, I.
    Liu, X.
    Lei, M.
    Kondo, K.
    Patel, A.
    Gricar, J.
    Chau, I.
    Kitagawa, Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 449 - 462
  • [33] Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma
    Hong, Min Hee
    Heo, Seong Gu
    Lee, Yun-Gyoo
    Kim, Hyo Song
    Park, Keon Uk
    Kim, Hoon-Gu
    Ko, Yoon Ho
    Chung, Ik-Joo
    Min, Young Joo
    Kim, Min Kyoung
    Kim, Kyu Ryung
    Yoo, Jinseon
    Kim, Tae-Min
    Kim, Hye Ryun
    Cho, Byoung Chul
    CANCER, 2020, 126 (20) : 4521 - 4531
  • [34] A phase 2, randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer
    Rainey, Natalie
    Joshi, Rohit
    Chiu, Joanne Win Yang
    Chen, Ann
    Wang, Hao
    Odegard, Jared
    Howland, Michael
    Adams, Sylvia
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
    Zeng, J.
    Cui, X.
    Cheng, L.
    Chen, Y.
    Du, X.
    Sheng, L.
    CANCER RADIOTHERAPIE, 2021, 25 (05): : 441 - 446
  • [36] Phase 2/3 study of livmoniplimab in combination with budigalimab in patients with locally advanced or metastatic hepatocellular carcinoma
    Abou-Alfa, Ghassan K.
    Bouattour, Mohamed
    Cheng, Ann-Lii
    Dayyani, Farshid
    Khalil, Danny
    Li, Daneng
    Liao, Chih-Yi
    Lopez, Carlos Lopez
    Rimassa, Lorenza
    Deutsch, Jonathan
    Pailden, Junvie
    Patel, Maulik
    Ng, Juki
    Henkel, Anne
    Ferlini, Cristiano
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
    Munhoz, Rodrigo R.
    Nader-Marta, Guilherme
    de Camargo, Veridiana P.
    Queiroz, Marcello M.
    Cury-Martins, Jade
    Ricci, Herminia
    de Mattos, Marcela R.
    de Menezes, Thiago A. F.
    Machado, Guilherme U. C.
    Bertolli, Eduardo
    Barros, Milton
    de Souza, Carina E.
    Franke, Fabio
    Ferreira, Fabio O.
    Feher, Olavo
    de Castro Jr, Gilberto
    CANCER, 2022, 128 (24) : 4223 - 4231
  • [38] Phase 2 Study of Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable Locally Advanced Esophageal Squamous Cell Carcinoma
    Wu, K.
    Wang, H.
    Fan, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E199 - E199
  • [39] Investigation of predictive biomarkers in patients treated with atezolizumab monotherapy following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802).
    Bando, Hideaki
    Kumagai, Shogo
    Kotani, Daisuke
    Mishima, Saori
    Habu, Takumi
    Tsushima, Takahiro
    Hara, Hiroki
    Kadowaki, Shigenori
    Kato, Ken
    Chin, Keisho
    Yamaguchi, Kensei
    Kageyama, Shun-ichiro
    Hojo, Hidehiro
    Nakamura, Masaki
    Hidenobu, Tachibana
    Wakabayashi, Masashi
    Fukui, Makoto
    Fuse, Nozomu
    Nishikawa, Hiroyoshi
    Kojima, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 416 - 416
  • [40] A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Wang, J.
    He, M.
    Yao, J.
    Cheng, Y.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S931 - S931
12345